ESC 2024 Atrial Fibrillation Guideline Test

Test your knowledge of the ESC 2024 atrial fibrillation guideline with explained multiple-choice questions. It covers the new AF-CARE framework, the CHA₂DS₂-VA score, anticoagulation and DOAC doses, bleeding risk, rate and rhythm control, cardioversion and ablation. Each question includes an explanation of the correct answer.

Atrial fibrillation 2024 (37 questions)

ESC 2024 atrial fibrillation guideline (AF-CARE framework).

  • Ablation (3)
  • Comorbidities and risk factors (3)
  • Rate control (3)
  • Rhythm control and cardioversion (6)
  • Diagnosis and screening (4)
  • Stroke prevention and anticoagulation (10)
  • Bleeding risk and left atrial appendage (3)
  • Special situations (5)

What the atrial fibrillation test covers

What's New in the ESC 2024 AF Guideline in 5 Points

  • Management is structured around the acronym AF-CARE, which gives prominence to controlling comorbidities and risk factors.
  • The CHA₂DS₂-VA replaces CHA₂DS₂-VASc: sex no longer scores.
  • The DOACs are preferred to vitamin K antagonists, except with mechanical valves or moderate-severe mitral stenosis.
  • To cardiovert without prior anticoagulation or TOE, the window becomes 24 hours from AF onset.
  • The ablation is recommended as a first-line option for rhythm control in paroxysmal AF, with shared decision-making.

If you want to revise before taking the test, see our guides on the approach to atrial fibrillation, its diagnosis, classification, treatment and the anticoagulation in AF.

Frequently asked questions

What changes in the ESC 2024 atrial fibrillation guideline?

It organises management with the AF-CARE scheme (comorbidities and risk factors, avoiding stroke and thromboembolism, reducing symptoms with rate and rhythm control, and dynamic evaluation), replaces CHA₂DS₂-VASc with CHA₂DS₂-VA (without sex), shortens to 24 hours the window for cardioversion without prior anticoagulation and reinforces ablation as a first-line option in paroxysmal AF.

What is the CHA₂DS₂-VA score?

It is the thromboembolic risk score proposed by the ESC 2024 guideline. It is the same as CHA₂DS₂-VASc but without scoring female sex. With 2 or more points anticoagulation is recommended, and with 1 point it should be considered. You can calculate it with our CHA₂DS₂-VA calculator.

Who is this test for?

For residents in cardiology, internal medicine, emergency medicine and family medicine, those preparing for specialty exams and specialists who want to revise the guideline. The questions are clinical level and include an explanation of the answer.

How many questions does the test have?

The question bank has more than 35 questions spread across the sections of the guideline. Each attempt selects 10 at random, and you can change the number, do only the ones you haven't seen or repeat the ones you got wrong.

Is it free and do I need to register?

It is free and requires no registration. Your progress is saved only in your browser.

Also practise with the 2024 hypertension test, the 2025 dyslipidaemia test and 2025 valvular heart disease test, or combine several topics in all the cardiology tests.